Significant unmet needs were found among high-quality validation studies on the internal structure of patient-reported ...

At Asembia’s AXS25 Summit, industry experts explored how pharmacy is evolving to meet rising patient expectations and ...

Efforts to more precisely select appropriate therapy for individual patients with rheumatoid arthritis have not yet yielded a ...

As the number of cell and gene therapies expands, it's increasingly important for long-term patient data, explained Fran ...

Jason Hawkes, MD, MS, provided an in-depth look at the potential role of dupilumab (Dupixent; Sanofi and Regeneron ...

Improving adherence to antiretroviral therapy (ART) in youth living with HIV requires interventions that target both family ...

Evaluating the impact of the Inflation Reduction Act (IRA) will require real-time data and effective therapy metrics, ...

Prademagene zamikeracel (Zevaskyn) is the first and only cell-based gene therapy for wound treatment in patients with ...

Early actions by the new administration signal major changes in health policy, taxes, and pharmaceutical pricing.

Disparities in prescribing semaglutide and tirzepatide for obesity reveal social factors affecting access and highlight the ...

K. "Vish" Viswanath, PhD, is a professor of population sciences at Dana-Farber Cancer Institute and a professor of health ...

Following results from their new retrospective study, the researchers suggested that immediate reconstruction of the nose ...